{"id":14645,"date":"2023-05-25T22:30:14","date_gmt":"2023-05-26T02:30:14","guid":{"rendered":"https:\/\/icesontario.wpengine.com\/?post_type=private_project&#038;p=14645"},"modified":"2025-02-28T11:23:29","modified_gmt":"2025-02-28T16:23:29","slug":"real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma","status":"publish","type":"private_project","link":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\/","title":{"rendered":"Real world impact of prescription eye drop therapy adherence on visual field progression among Ontario patients with open-angle glaucoma"},"content":{"rendered":"\n<p><strong>Client: <\/strong>IQVIA Solutions Canada Inc.<br><br><strong>Project ID:<\/strong> P2022-112 \/ 2023 0970 332 000<\/p>\n\n\n\n<p><strong>Research Question\/Objectives:<\/strong> The client has several objectives around the treatment of intraocular pressure (IOP).<\/p>\n\n\n\n<p><strong>To describe:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>the proportion of patients in monotherapy, dual therapy or multiple agents at index, 12-, 24-, 36-, 60-, 84-, and 120-months post-index.<\/li>\n\n\n\n<li>the average duration of IOP-lowering prescription eye drop use prior to the occurrence of a non-eye drop intervention for POAG, initiation of an oral IOP-lowering medication or treatment discontinuation for patient on IOP-lowering prescription eye drops for at least 5 years<\/li>\n\n\n\n<li>the rate of switching and treatment escalation following the initiation of the index IOP-lowering prescription eye drop therapy.<\/li>\n\n\n\n<li>the rate of discontinuation of IOP-lowering prescription eye drops by class and combination of classes of medication for patients on IOP-lowering prescription eye drops for at least 5 years<\/li>\n\n\n\n<li>patient adherence to index treatment overall and for each class and combination of classes of IOP-lowering prescription eye drops medication at 3-, 6-, 12- and 24-months post-index for patients on IOP-lowering prescription eye drops for at least 5 years.<\/li>\n\n\n\n<li>healthcare resource utilization (HCRU) including, but not limited to, physician and hospital visits for eye care of patients using IOP-lowering prescription eye drops overall, by class and combination of classes of medication.<\/li>\n\n\n\n<li>time to and type of eye procedures for PAG diagnosis for patients on IOP-lowering prescription eye drops for at least 5 years<\/li>\n<\/ul>\n\n\n\n<p><strong>Status:<\/strong> Completed<br><br><strong>Results: <\/strong>September 2024<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Client: IQVIA Solutions Canada Inc. Project ID: P2022-112 \/ 2023 0970 332 000 Research Question\/Objectives: The client has several objectives around the treatment of intraocular pressure (IOP). To describe: Status: Completed Results: September 2024<\/p>\n","protected":false},"template":"","organization_type":[],"project_status":[105],"response_type":[],"class_list":["post-14645","private_project","type-private_project","status-publish","hentry","project_status-completed"],"acf":{"project_id":"P2022-112 \/ 2023 0970 332 000","project_id_year":2022,"project_id_index":38,"ices_scientist":"","principal_investigators":null,"knowledge_user":"","client":"","objectives":"","results":"","availability_of_results":"","pia_approved":null,"infographic":"","sitecore_item_id":"","sitecore_item_name":"","sitecore_field_values":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Real world impact of prescription eye drop therapy adherence on visual field progression among Ontario patients with open-angle glaucoma | ICES<\/title>\n<meta name=\"description\" content=\"Client: IQVIA Solutions Canada Inc.Project ID: P2022-112 \/ 2023 0970 332 000 Research Question\/Objectives: The client has several objectives around the\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Real world impact of prescription eye drop therapy adherence on visual field progression among Ontario patients with open-angle glaucoma | ICES\" \/>\n<meta property=\"og:description\" content=\"Client: IQVIA Solutions Canada Inc.Project ID: P2022-112 \/ 2023 0970 332 000 Research Question\/Objectives: The client has several objectives around the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-28T16:23:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\\\/\",\"name\":\"Real world impact of prescription eye drop therapy adherence on visual field progression among Ontario patients with open-angle glaucoma | ICES\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2023-05-26T02:30:14+00:00\",\"dateModified\":\"2025-02-28T16:23:29+00:00\",\"description\":\"Client: IQVIA Solutions Canada Inc.Project ID: P2022-112 \\\/ 2023 0970 332 000 Research Question\\\/Objectives: The client has several objectives around the\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Private Sector Projects\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Real world impact of prescription eye drop therapy adherence on visual field progression among Ontario patients with open-angle glaucoma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Real world impact of prescription eye drop therapy adherence on visual field progression among Ontario patients with open-angle glaucoma | ICES","description":"Client: IQVIA Solutions Canada Inc.Project ID: P2022-112 \/ 2023 0970 332 000 Research Question\/Objectives: The client has several objectives around the","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\/","og_locale":"fr_FR","og_type":"article","og_title":"Real world impact of prescription eye drop therapy adherence on visual field progression among Ontario patients with open-angle glaucoma | ICES","og_description":"Client: IQVIA Solutions Canada Inc.Project ID: P2022-112 \/ 2023 0970 332 000 Research Question\/Objectives: The client has several objectives around the","og_url":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2025-02-28T16:23:29+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\/","url":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\/","name":"Real world impact of prescription eye drop therapy adherence on visual field progression among Ontario patients with open-angle glaucoma | ICES","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2023-05-26T02:30:14+00:00","dateModified":"2025-02-28T16:23:29+00:00","description":"Client: IQVIA Solutions Canada Inc.Project ID: P2022-112 \/ 2023 0970 332 000 Research Question\/Objectives: The client has several objectives around the","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/real-world-impact-of-prescription-eye-drop-therapy-adherence-on-visual-field-progression-among-ontario-patients-with-open-angle-glaucoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Private Sector Projects","item":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/"},{"@type":"ListItem","position":3,"name":"Real world impact of prescription eye drop therapy adherence on visual field progression among Ontario patients with open-angle glaucoma"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/private_project\/14645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/private_project"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/private_project"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=14645"}],"wp:term":[{"taxonomy":"organization_type","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/organization_type?post=14645"},{"taxonomy":"project_status","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/project_status?post=14645"},{"taxonomy":"response_type","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/response_type?post=14645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}